FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

G-Tech Medical Myoelectric Measurer Cleared

FDA has cleared a G-Tech Medical 510(k) for its Wireless Patch System for myoelectric activity measurement as an aid in diagnosing and treating gastro...

Federal Register

FDA Revoking 3 Covid Tests

Federal Register notice: FDA revokes the Emergency Use Authorizations issued to Becton, Dickinson for the BioGX SARSCoV2 Reagents for BD MAX System, B...

FDA General

Senate Health Committee Advances Califf Nomination

The Senate Health, Education, Labor & Pensions Committee votes to move FDA commissioner nominee Robert Califfs nomination to an eventual Senate floor ...

Biologics

FDA Revises Janssen Vaccine Fact Sheets

FDA revises fact sheets for the Janssen Covid-19 vaccine to discuss the risk of immune thrombocytopenia during the 42 days after vaccination.

Medical Devices

FDA Extends Expiration on Covid Tests in Florida

FDA extends the expiration date on about one million unused Covid test kits in Florida.

Human Drugs

Dental Issues with Some Buprenorphine Use: FDA

FDA warns patients and providers about the potential for dental problems associated with dissolving buprenorphine products in the mouth to treat opioi...

Human Drugs

Mitsubishi Tanabe NDA for Oral ALS Drug

FDA accepts for priority review a Mitsubishi Tanabe Pharma America NDA for edaravone (MT-1186) for treating amyotrophic lateral sclerosis.

Human Drugs

CMS Questions FDA Aduhelm Approval: Analysis

Washington University in St. Louis law professor Rachel Sachs says a CMS restricted coverage determination for Biogens Aduhelm adds to questions about...

Human Drugs

Novartis Seeking EUA for Covid Therapeutic

Novartis and Molecular Partners say they plan to seek an FDA emergency use authorization after reporting results from the EMPATHY clinical trial that...

Human Drugs

Skinny Label Allowed Faster Generic Entry: Study

Harvard Medical School researchers say the use of skinny labeling in generic forms of Novartis Gleevec allowed the generics to enter the market before...